Redmile Group LLC 13D and 13G filings for Krystal Biotech, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 9:00 pm Sale |
2024-09-30 | 13G | Krystal Biotech, Inc. KRYS |
Redmile Group LLC | 810,245 2.800% |
-922,944 (-53.25%) |
Filing |
| 2024-02-14 4:26 pm Sale |
2023-12-31 | 13G | Krystal Biotech, Inc. KRYS |
Redmile Group LLC | 1,733,189 6.100% |
-163,456 (-8.62%) |
Filing |
| 2023-02-14 4:27 pm Purchase |
2022-12-31 | 13G | Krystal Biotech, Inc. KRYS |
Redmile Group LLC | 1,896,645 7.400% |
75,747 (+4.16%) |
Filing |
| 2022-02-14 5:07 pm Purchase |
2021-12-31 | 13G | Krystal Biotech, Inc. KRYS |
Redmile Group LLC | 1,820,898 7.300% |
145,862 (+8.71%) |
Filing |
| 2021-02-16 4:08 pm Purchase |
2020-12-31 | 13G | Krystal Biotech, Inc. KRYS |
Redmile Group LLC | 1,675,036 8.500% |
584,836 (+53.64%) |
Filing |